45612 Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on February 27, 2017 (82 FR 11942). 

Patricia A. Brink, 

Director of Civil Enforcement, Antitrust 

Division. 

[FR Doc. 2017–20880 Filed 9–28–17; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: Registrants listed below have 

applied for and been granted 

registration by the Drug Enforcement 

Administration as importers of various 

classes of schedule I or II controlled 

substances. 

SUPPLEMENTARY INFORMATION: The 

companies listed below applied to be 

registered as importers of various basic 

classes of controlled substances. 

Information on previously published 

notices is listed in the table below. No 

comments or objections were submitted 

and no requests for hearing were 

submitted for these notices. 

Company FR docket Published 

United States Pharmacopeial.

Convention ................................................................................. 82 FR 34694 ............................................................................ July 26, 2017. 

AMRI Rensselaer, Inc ................................................................ 82 FR 34696 ............................................................................ July 26, 2017. 

R & D Systems, Inc ................................................................... 82 FR 35546 ............................................................................ July 31, 2017. 

Sigma-Aldrich International.

GMBH ........................................................................................ 82 FR 35547 ............................................................................ July 31, 2017. 

Cambrex High Point, Inc ........................................................... 82 FR 35992 ............................................................................ August 2, 2017. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of the listed registrants to 

import the applicable basic classes of 

schedule I or II controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated each company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing each company’s physical 

security systems, verifying each 

company’s compliance with state and 

local laws, and reviewing each 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the DEA has 

granted a registration as an importer for 

schedule I or II controlled substances to 

the above listed persons. 

Dated: September 21, 2017. 

Demetra Ashley, 

Acting Assistant Administrator. 

[FR Doc. 2017–20943 Filed 9–28–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Cody Laboratories, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 30, 2017. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 30, 2017. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 3417 

(January 25, 2007). 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on June 

16, 2017, Cody Laboratories, Inc., Steve 

Hartman, 601 Yellowstone Avenue, 

Cody, Wyoming 82414–9321 applied to 

be registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled substance Drug 

code Schedule 

Phenylacetone .............. 8501 II 

Poppy Straw Concentrate.9670 II 

Tapentadol .................... 9780 II 

The company plans to import narcotic 

raw materials to manufacture bulk 

controlled substances for distribution to 

its customers. The company plans to 

import an intermediate form of 

tapentadol (9870), to bulk manufacture 

tapentadol for distribution to its 

customers. 

Dated: September 21, 2017. 

Demetra Ashley, 

Acting Assistant Administrator. 

[FR Doc. 2017–20942 Filed 9–28–17; 8:45 am] 

BILLING CODE 4410–09–P 


asabaliauskas on DSKBBXCHB2PROD with NOTICES